ERBB2 and cancer: Because we were unable to identify a CDK inhibitor-treated breast cancer cohort with publicly available gene expression and treatment response data, we examined gene expression and drug response data in the Cancer Cell Line Encyclopedia [25] for five ER-positive/HER2-negative human breast cancer cell lines.